| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 21.858 | 226.013 | 319.708 |
| Total Income - EUR | - | - | - | - | - | - | - | 21.859 | 226.598 | 320.741 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 33.875 | 165.349 | 268.767 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -12.016 | 61.248 | 51.974 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -12.235 | 51.644 | 45.140 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Inova Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 86 | 30.011 | 28.186 |
| Current Assets | - | - | - | - | - | - | - | 18.186 | 145.385 | 213.147 |
| Inventories | - | - | - | - | - | - | - | 13.513 | 10.809 | 45.283 |
| Receivables | - | - | - | - | - | - | - | 2.771 | 111.498 | 113.680 |
| Cash | - | - | - | - | - | - | - | 1.902 | 23.077 | 54.184 |
| Shareholders Funds | - | - | - | - | - | - | - | -18.383 | 33.317 | 78.271 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 36.655 | 142.079 | 163.062 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Inova Pharma S.r.l.